Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  1. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Clinical and histopathological predictors of outcome in malignant meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer


OriginalsprogEngelsk
Publikationsdato2016
StatusUdgivet - 2016
BegivenhedThe Scandinavian Society of Neuro-Oncology: Meeting 2016 - Odd Fellow Palace, Copenhagen, Danmark
Varighed: 19 maj 201621 maj 2016

Konference

KonferenceThe Scandinavian Society of Neuro-Oncology
LokationOdd Fellow Palace
LandDanmark
ByCopenhagen
Periode19/05/201621/05/2016

Begivenhed

The Scandinavian Society of Neuro-Oncology: Meeting 2016

19/05/201621/05/2016

Copenhagen, Danmark

Begivenhed: Konference

ID: 49850355